27 related articles for article (PubMed ID: 26552826)
1. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
[TBL] [Abstract][Full Text] [Related]
2. Profiling of active thrombin in human blood by supramolecular complexes.
Müller J; Becher T; Braunstein J; Berdel P; Gravius S; Rohrbach F; Oldenburg J; Mayer G; Pötzsch B
Angew Chem Int Ed Engl; 2011 Jun; 50(27):6075-8. PubMed ID: 21591028
[No Abstract] [Full Text] [Related]
3. Effects of argatroban on thrombin-induced events in cultured vascular smooth muscle cells.
Hijikata-Okunomiya A; Nakaya Y; Inoue N; Takahashi A; Taniguchi T; Wanaka K; Tsuda Y; Okada Y; Ishikawa Y
Thromb Res; 2000 Feb; 97(4):257-62. PubMed ID: 10674413
[No Abstract] [Full Text] [Related]
4. The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
Asanuma K; Wakabayashi H; Okamoto T; Asanuma Y; Akita N; Yoshikawa T; Hayashi T; Matsumine A; Uchida A; Sudo A
Breast Cancer; 2013 Jul; 20(3):241-6. PubMed ID: 22359194
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of a new DNA aptamer, direct inhibitor of thrombin.
Mazurov AV; Titaeva EV; Khaspekova SG; Storojilova AN; Spiridonova VA; Kopylov AM; Dobrovolsky AB
Bull Exp Biol Med; 2011 Feb; 150(4):422-5. PubMed ID: 22268033
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Based Enzyme Capture Assay for Measurement of Plasma Thrombin Levels.
Müller J; Becher T; Mayer G; Pötzsch B
Methods Mol Biol; 2016; 1380():179-89. PubMed ID: 26552826
[TBL] [Abstract][Full Text] [Related]
7. G-Quadruplex Aptamers to Human Thrombin Versus Other Direct Thrombin Inhibitors: The Focus on Mechanism of Action and Drug Efficiency as Anticoagulants.
Zavyalova E; Ustinov N; Golovin A; Pavlova G; Kopylov A
Curr Med Chem; 2016; 23(21):2230-44. PubMed ID: 27183984
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of argatroban.
Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
[TBL] [Abstract][Full Text] [Related]
9. [Experimental and clinical results with the thrombin inhibitor Argatroban].
Breddin HK
Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule direct antithrombins: argatroban.
Fareed J; Jeske WP
Best Pract Res Clin Haematol; 2004 Mar; 17(1):127-38. PubMed ID: 15171962
[TBL] [Abstract][Full Text] [Related]
11. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
LaMonte MP; Brown PM; Hursting MJ
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
